Ironwood Pharmaceuticals to Participate in The JMP Securities Life Sciences Conference
09 Maio 2023 - 5:01PM
Business Wire
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced
that management will participate in a fireside chat at The JMP
Securities Life Sciences Conference on Tuesday, May 16, 2023 at
1:30 p.m. ET at the New York Hilton Midtown.
A live audio webcast of Ironwood’s fireside chat will be
accessible through the Investors section of the company’s website
at www.ironwoodpharma.com. To access the webcast, please log on to
the Ironwood website approximately 15 minutes prior to the start
time to ensure adequate time for any software downloads that may be
required. A replay of the webcast will be available on Ironwood’s
website for 14 days following the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap
600® company, is a leading gastrointestinal (GI) healthcare company
on a mission to advance the treatment of GI diseases and redefine
the standard of care for GI patients. We are pioneers in the
development of LINZESS® (linaclotide), the U.S. branded
prescription market leader for adults with irritable bowel syndrome
with constipation (IBS-C) or chronic idiopathic constipation (CIC).
Under the guidance of our seasoned industry leaders, we continue to
build upon our history of GI innovation and challenge what has been
done before to shape what the future holds. We keep patients at the
heart of our R&D and commercialization efforts to reduce the
burden of GI diseases and address significant unmet needs.
Founded in 1998, Ironwood Pharmaceuticals is headquartered in
Boston, Massachusetts.
We routinely post information that may be important to investors
on our website at www.ironwoodpharma.com. In addition, follow us on
Twitter and on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230509005003/en/
Investors:
Greg Martini, 617-374-5230 gmartini@ironwoodpharma.com
Matt Roache, 617-621-8395 mroache@ironwoodpharma.com
Media:
Beth Calitri, 978-417-2031 bcalitri@ironwoodpharma.com
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
